ArticlePharmaceuticals (Basel, Switzerland)2022

Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.